Search Results
Dr David Snyder on Responses to Ruxolitinib in Patients With Acute GVHD
Dr David Snyder on When to Add Ruxolitinib to Treat GVHD
Dr David Snyder Discusses Treating GVHD, the Differences Between Chronic and Acute GVHD
Dr David Snyder Outlines Use of Ruxolitinib After Approval of Fedratinib
Case 3: Ruxolitinib for Steroid-Refractory Acute GVHD
Implications for Treating Acute GVHD With Ruxolitinib
Clinical Perspective: Integrating Ruxolitinib into the Treatment of Acute GVHD
Ruxolitinib Appears Promising as Treatment of Chronic Graft-Versus-Host Disease
Ruxolitinib for Steroid-Refractory Acute GVHD
Dr. Snyder on Transplant Updates in Myelofibrosis
Utilizing JAK Inhibition to Treat Acute GVHD
Case 1: Personal Approach to Treatment for Acute GVHD
